2026-04-25T03:47:39Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:21494 2025-12-19T04:43:59Z

Sorafenib as first line treatment for advanced liver cancer-are expiries. Ann Oncol (2011) 23 (suppl 4): iv 57. J. Rožić, Z. Gojković, S. Jungić, I. Rakita, Ž. Vranješ, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, P. Dašić, M. Vižin, Sorafenib as first line treatment for advanced liver cancer-are expiries. Ann Oncol (2011) 23 (suppl 4): iv 57., This article appears in ESMO 13th World Congres of Gastrointestinal Cancer, 22-25 june 2011., 2011. /unibl/sci/idNaucniRad:8551 Article text 2011 J. Rožić, Z. Gojković, S. Jungić, I. Rakita, Ž. Vranješ, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, P. Dašić, M. Vižin, Sorafenib as first line treatment for advanced liver cancer-are expiries. Ann Oncol (2011) 23 (suppl 4): iv 57., This article appears in ESMO 13th World Congres of Gastrointestinal Cancer, 22-25 june 2011., 2011 This article appears in ESMO 13th World Congres of Gastrointestinal Cancer, 22-25 june 2011. /unibl/author/Jelena Rožić https://www.unibl.org/sr-lat/fis/zaposlen/3371-zdenka-gojkovic /unibl/author/S Jungić /unibl/author/Ivanka Rakita /unibl/author/Ž Vranješ /unibl/author/R Rašeta /unibl/author/G Marić /unibl/author/M Vještica /unibl/author/S Mijatović /unibl/author/Predrag Dašić /unibl/author/M Vižin This article appears in ESMO 13th World Congres of Gastrointestinal Cancer, 22-25 june 2011. /unibl/author/Jelena Rožić https://www.unibl.org/sr-lat/fis/zaposlen/3371-zdenka-gojkovic /unibl/author/S Jungić /unibl/author/Ivanka Rakita /unibl/author/Ž Vranješ /unibl/author/R Rašeta /unibl/author/G Marić /unibl/author/M Vještica /unibl/author/S Mijatović /unibl/author/Predrag Dašić /unibl/author/M Vižin https://www.pub.unibl.org/s/cir/item/21494